{"result": "(\"entity\"<|>MAMMALS<|>ORGANIZATION<|>Mammals are a class of animals characterized by the presence of mammary glands, which produce milk for feeding their young.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic health condition that affects how the body processes blood sugar (glucose).)\n##\n(\"entity\"<|>NUTRITIONAL INTERVENTION<|>EVENT<|>Nutritional intervention refers to dietary changes made to improve health outcomes, particularly in relation to obesity and metabolic disorders.)\n##\n(\"entity\"<|>METABOLIC DISORDERS<|>EVENT<|>Metabolic disorders are conditions that disrupt normal metabolism, the process of converting food to energy.)\n##\n(\"entity\"<|>ANTIBIOTICS<|>ORGANIZATION<|>Antibiotics are medications used to treat bacterial infections, which can also affect the gut microbiome.)\n##\n(\"relationship\"<|>NUTRITIONAL INTERVENTION<|>OBESITY<|>Nutritional intervention is often employed as a strategy to prevent or treat obesity<|>7)\n##\n(\"relationship\"<|>DIABETES<|>OBESITY<|>Obesity is a significant risk factor for the development of diabetes<|>9)\n##\n(\"relationship\"<|>ANTIBIOTICS<|>METABOLIC DISORDERS<|>The use of antibiotics can influence the development of metabolic disorders through changes in gut microbiota<|>6)\n##\n(\"relationship\"<|>MAMMALS<|>DIABETES<|>Certain mammals, including humans, are affected by diabetes, which can be influenced by dietary factors<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: -              y cambios en filos como            Firmicutes, Bacteroidetes          y\nmento tras intervención nutricional mediante el uso de                Proteobacteria. Además, varios experimentos 47 han de-\nprebióticos invierten trastornos metabólicos inducidos                mostrado que el uso de tratamientos antibióticos de\npor una dieta alta en grasas, de ahí su posible implica-              amplio espectro como la vancomicina puede incre-\nción en la prevención y/o tratamiento de la obesidad y                mentar la abundancia de Akkermansia muciniphila en\nsus complicaciones41. Los mecanismos propuestos por                   roedores, reduciendo la incidencia de diabetes. Asimis-\nlos que el uso de prebióticos mejora la salud intestinal y            mo, Cani et al, apoyan que la antibioterapia de amplio\nreduce las complicaciones metabólicas de la obesidad                  espectro reduce significativamente los niveles plasmáti-\nincluyen: 1) aumento de la población de                 Bifidobacte-  cos de lipopolisacáridos (LPS) en modelos animales48.\nrium, que como ya hemos comentado, se correlaciona                    En sus estudios, Membrez             et al49, objetivaron cómo\npositivamente con la salud intestinal y negativamente                 roedores genéticamente obesos que presentaban resis-\ncon la obesidad y la diabetes. 2) Reducción de endo-                  tencia a la insulina y que estaban sometidos a una die-\ntoxemia metabólica a través de una mayor función de                   ta alta en grasas mejoraron la tolerancia a la glucosa y\nbarrera del intestino. 3) Aumento de las señales de sa-               el peso al someterse a tratamiento antibiótico. El uso\nciedad del intestino, tales como la producción del                    de antibioterapia redujo el grado de inflamación del\npéptido YY o la reducción de ghrelina. 4) Mejoría en                  tejido adiposo, así como el estrés oxidativo y la infiltra-\nla acción de la insulina mediante el aumento de secre-                ción de macrófagos del mismo.\nción de GLP-1. 5) Reducción de la adipogénesis median-                   De otro lado, algunos estudios han asociado la expo-\nte síntesis de ácidos grasos de cadena corta (SCFA)36.                sición a antibióticos con aumentos de la masa corporal\n                                                                      en diferentes circunstancias, como son los primeros\n2.4.    Pérdida de biodiversidad de nuestra                           meses de la vida, durante la infancia, en sujetos desnu-\n        microbiota intestinal                                         tridos, animales, infectados por             H. pylori, enfermos\n                                                                      con fibrosis quística, etc. sin poder discernir si este\n   La evidencia existente apunta hacia un cambio im-                  aumento de peso es debido a los efectos beneficiosos\nportante de la microbiota intestinal en las últimas dé-               del tratamiento antibiótico en la prevención o trata-\ncadas, aumentando la presencia de determinadas es-                    miento de infecciones bacterianas o a través de sus\n---\n 174      BLOQUE: ALTERACIONES DE LA ENERGÍA\n\n\n\nefectos sobre la microbiota, siendo plausible que estén    crito anteriormente, se han producido en las últimas\npresentes una mezcla de estos dos mecanismos en mu-        décadas.\nchos de los escenarios descritos50-54.                        Se entiende que el origen de la obesidad es un reto\n   Estudios epidemiológicos han apoyado el aumento         complicado debido a la gran diversidad genética y las\ndel riesgo de sobrepeso en la infancia tardía con la ex-   diferencias sociales entre los seres humanos. Por lo tan-\nposición a terapia antibiótica en la primera infancia55.   to, las muchas historias naturales que existen son obstá-\nIncluso han relacionado el progresivo aumento de obe-      culos que ralentizan la investigación para identificar las\nsidad poblacional con el uso creciente de antibióti-       diversas causas de la actual epidemia de la obesidad.\ncos56, 57 . Durante décadas, dosis subterapéuticas de      Durante más de medio siglo, y desde que se han llevado\nantibióticos se han utilizado para promover el creci-      a cabo avances en biología molecular, la comunidad\nmiento de animales de granja, con incremento de            científica ha estado investigando sobre el origen genéti-\nmasa grasa, relacionándose incluso el uso creciente de     co de las enfermedades metabólicas. A pesar de los tre-\nantibióticos con el aumento de la obesidad58, 59. En       mendos esfuerzos y la identificación de algunas muta-\ncontraste con estas observaciones, la exposición a anti-   ciones puntuales en el genoma, no se ha elaborado una\nbióticos en los primer\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>FIRMICUTES<|>ORGANIZATION<|>Firmicutes is a type of bacteria that plays a role in human gut health and metabolism.)\n##\n(\"entity\"<|>BACTEROIDETES<|>ORGANIZATION<|>Bacteroidetes is a phylum of bacteria that is significant in the human gut microbiome.)\n##\n(\"entity\"<|>PROTEOBACTERIA<|>ORGANIZATION<|>Proteobacteria is a major phylum of bacteria that includes many pathogens and is involved in various metabolic processes.)\n##\n(\"entity\"<|>AKKERMANSIA MUCINIPHILA<|>ORGANIZATION<|>Akkermansia muciniphila is a beneficial bacterium in the gut that is associated with improved metabolic health.)\n##\n(\"entity\"<|>GLP-1<|>ORGANIZATION<|>GLP-1 (Glucagon-like peptide-1) is a hormone involved in glucose metabolism and appetite regulation.)\n##\n(\"entity\"<|>H. PYLORI<|>ORGANIZATION<|>H. pylori is a type of bacteria that can infect the stomach and is associated with various gastrointestinal diseases.)\n##\n(\"entity\"<|>FIBROSIS QUÍSTICA<|>ORGANIZATION<|>Fibrosis quística (Cystic fibrosis) is a genetic disorder that affects the lungs and digestive system.)\n##\n(\"entity\"<|>ANTIBIOTIC THERAPY<|>EVENT<|>Antibiotic therapy refers to the use of antibiotics to treat bacterial infections, which can impact gut microbiota.)\n##\n(\"entity\"<|>OBESITY<|>EVENT<|>Obesity is a complex health condition characterized by excessive body fat, often linked to metabolic disorders.)\n##\n(\"relationship\"<|>FIRMICUTES<|>BACTEROIDETES<|>Firmicutes and Bacteroidetes are two major phyla of bacteria that are often studied together in relation to gut health and obesity<|>7)\n##\n(\"relationship\"<|>PROTEOBACTERIA<|>H. PYLORI<|>Proteobacteria includes H. pylori, which is a significant pathogen affecting gut health<|>8)\n##\n(\"relationship\"<|>AKKERMANSIA MUCINIPHILA<|>OBESITY<|>Akkermansia muciniphila is associated with reduced obesity and improved metabolic health<|>9)\n##\n(\"relationship\"<|>GLP-1<|>OBESITY<|>GLP-1 plays a role in regulating appetite and glucose metabolism, which are critical in obesity management<|>8)\n##\n(\"relationship\"<|>ANTIBIOTIC THERAPY<|>OBESITY<|>Antibiotic therapy has been linked to changes in gut microbiota that may influence obesity risk<|>6)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>H. PYLORI<|>Patients with fibrosis quística may have increased susceptibility to H. pylori infections<|>5)\n<|COMPLETE|>"}]}